SPONSOR
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Total Trials
5
Recruiting
5
Phases
Phase 3, Phase 2, Phase 1
Conditions studied: Non-small Cell Lung CancerB-cell LymphomaVasodilatory ShockChronic Obstructive Pulmonary Disease (COPD)Generalized Pustular Psoriasis
NCT05922345 Phase 3
Recruiting
Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.
Non-small Cell Lung Cancer
NCT06566586 Phase 2
Recruiting
A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma
B-cell Lymphoma
NCT06351150 Phase 3
Recruiting
Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock
Vasodilatory Shock
NCT06748079 Phase 1
Recruiting
A Clinical Study of TQC3721 Inhalation Powder in Patients With Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
NCT07314060 Phase 2
Recruiting
A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis
Generalized Pustular Psoriasis